Renal Cell Cancer Update

Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/MonoclonalAntibodiesMM23)

Dr Kristen K Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and Dr J Randolph Hecht from UCLA’s David Geffen School of Medicine in Santa Monica, California, discuss the current management and actual cases of relapsed/refractory metastatic colorectal cancer moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/RRmCRC2023)

Dr Naveen Pemmaraju from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging management approaches for blastic plasmacytoid dendritic cell neoplasms moderated by Dr Neil Love. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayBPDCN23)

Dr Hope Rugo from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Tiffany Traina from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging optimal management approaches for metastatic triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/InsideTheIssue2023/TNBC)

Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of CELMoDs and other novel approaches to targeting protein degradation pathways in the treatment of multiple myeloma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayCELMoDsMM23)

Dr Debra L Richardson from OU Health Stephenson Cancer Center in Oklahoma City discusses novel agents and strategies for ovarian cancer moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayNovelAgentsOvarian23)

Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the spectrum of toxicities associated with BTK inhibitors and strategies for their mitigation and management for patients with chronic lymphocytic leukemia and mantle cell lymphoma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/BTKToxicities23)

Dr Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/mPancreatic)

Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://researchtopractice.com/InsidetheIssue2023/NHL)

Prof Georgina Long from the University of Sydney in Sydney, New South Wales, Australia, discusses optimizing the management of melanoma moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/MTPMelanoma23)

Dr Corey Langer, Dr Ticiana Leal, Dr Karen Reckamp and Dr Jacob Sands discuss the optimal current management of relapsed NSCLC and provide perspectives on the future of care for patients with this disease, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/RelapsedmNSCLCThinkTank2023)

Dr Ghassan Abou-Alfa from Memorial Sloan Kettering Cancer Center in New York and Dr Daneng Li from City of Hope Comprehensive Cancer Center in Duarte, California, discuss the implications of recent data sets for the management of hepatocellular carcinoma moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://researchtopractice.com/PostESMOGI23/HCC)

Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/HigherRiskProstate)

Featuring a discussion on BTK inhibitors for the management of mantle cell lymphoma with Dr Michael Wang, moderated by Dr Neil Love. CME information and select publications here (https://researchtopractice.com/OncologyTodayBTKInhibitorsMCL23).

Dr Richard F Riedel from Duke Cancer Institute in Durham, North Carolina, discusses approved and novel treatment approaches for soft tissue sarcoma, moderated by Dr Neil Love. CME information and select publications here (http://www.ResearchToPractice.com/MTPSarcoma23/Part2).

Dr Jeremy Abramson from Massachusetts General Hospital in Boston discusses key presentations on chronic lymphocytic leukemia and lymphomas from recent oncology/hematology conferences. CME information and select publications here (https://researchtopractice.com/OncologyTodayPostConf23/CLLLymphoma)

Dr Rana McKay from UC San Diego Moores Cancer Center in La Jolla, California discusses key presentations on genitourinary cancers from the 2023 ASCO Annual Meeting. CME information and select publications here (https://researchtopractice.com/OncologyTodayPostASCO23/GU)

Dr Aditya Bardia from Massachusetts General Hospital in Boston, Massachusetts, and Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discuss approved and novel treatment approaches for ER-positive metastatic breast cancer that has progressed on prior CDK4/6 inhibitor therapy. CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/ERPositivemBC).

Dr Hans Lee from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York, New York, discuss approved and novel bispecific antibodies and their current and potential roles in the treatment of multiple myeloma. CME information and select publications here (https://www.researchtopractice.com/InsidetheIssue2023/MM).

Dr Matthew Gubens from the University of California in San Francisco, California, discusses key presentations on lung cancer from the 2023 ASCO Annual Meeting moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://ResearchToPractice.com/OncologyTodayPostASCO23/Lung)